Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,672.00    -84.00 (-1.77%)
Bid:
4,656.00
Ask:
4,662.00
Spread: 6.00 (0.129%)
Market Cap: £2.18b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Pre-close trading update

17 Dec 2009 07:00

RNS Number : 2597E
Morgan Sindall PLC
17 December 2009
 



17 Dec 2009

Morgan Sindall plc

Morgan Sindall plc, the construction and regeneration group, provides the following period end trading update in advance of the announcement of its preliminary results for the year ended 31 December 2009, expected to be in late February 2010. 

Trading

As previously announced in our Interim Management Statement on 10 November, Morgan Sindall remains on track to achieve its expectations for the current year, despite the challenging market conditions in which it is operating. 

Fit Out is performing strongly in tough market conditions with margins remaining robust and it continues to see a recovery in the level of tendering activity.

Construction is still experiencing healthy demand from the public sector and, in particular, is currently advancing two major projects at preferred bidder stage, Tayside Mental Health (£100m) and Hull BSF (£200m). We expect to achieve financial close on these projects during the first quarter of 2010. There remains considerable uncertainty over future public spending commitments.

Infrastructure Services continues to perform well in reasonably buoyant market conditions and the division continues to progress a number of major opportunities. Although the bidding processes are proving more protracted than initially anticipated, we continue to await the outcome of preferred bidder decisions on a number of contracts. 

Affordable Housing is still seeing a reasonable pipeline of refurbishment and new build social housing opportunities. This is complemented by improvements in demand for open market housing with sales continuing to improve.

Urban Regeneration's market remains subdued although we expect recovery in market conditions in the longer term.

The Investments division is seeing a strong pipeline of opportunities and we expect that it will increase its level of bidding activity in 2010, thereby taking advantage of the Group's increasing ability to deliver larger and more complex projects since the acquisition made in 2007.

Outlook

The Group's forward order book has reduced from £3.6bn to £3.2bn since 30 June 2009. However, this forward order book is supplemented by over £900m of projects at preferred bidder stage, all of which have been awarded during the second half of this year. 

We remain mindful of the challenges facing the sector in the longer term and continue to shape our business accordingly. Each of our divisions continues to particularly focus on cash management, cost reduction and supply chain improvements, as well as responding to market growth opportunities where they present themselves.

In summary, Morgan Sindall is on track to meet our expectations for 2009 and is well placed to meet the challenges and opportunities in 2010.

Enquiries:

Morgan Sindall plc

Tel: 020 7307 9200

Paul Smith, Chief Executive

David Mulligan, Finance Director

Blythe Weigh Communications

Tel: 020 7138 3204 

Tim Blythe

Mob: 07816 924626

Paul Weigh

Mob: 07989 129658 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTCKAKBOBDDNBD
Date   Source Headline
12th Aug 20249:52 amRNSHolding(s) in Company
9th Aug 20244:50 pmRNSHolding(s) in Company
8th Aug 20247:00 amRNSRESULTS FOR THE HALF YEAR (HY) ENDED 30 JUNE 2024
1st Aug 20249:36 amRNSTotal Voting Rights
30th Jul 202410:29 amRNSHolding(s) in Company
29th Jul 20244:48 pmRNSHolding(s) in Company
24th Jul 20247:00 amRNSDirectorate Change
9th Jul 20245:37 pmRNSHolding(s) in Company
9th Jul 20242:49 pmRNSTotal Voting Rights
8th Jul 20247:00 amRNSNotice of Half Year Results
1st Jul 202411:23 amRNSTotal Voting Rights
27th Jun 20248:53 amRNSCompany Secretary Change
26th Jun 20243:12 pmRNSHolding(s) in Company
19th Jun 202410:35 amRNSDirectorate Change
13th Jun 20243:50 pmRNSHolding(s) in Company
7th Jun 20244:43 pmRNSHolding(s) in Company
4th Jun 20243:12 pmRNSAdditional Listing
3rd Jun 20249:55 amRNSTotal Voting Rights
14th May 20243:08 pmRNSDirector/PDMR Shareholding
2nd May 20242:09 pmRNSResult of AGM
2nd May 20247:00 amRNSTrading Update
1st May 20249:40 amRNSTotal Voting Rights
22nd Apr 202410:35 amRNSBlock listing Interim Review
8th Apr 20247:00 amRNSDirectorate Changes: Update
2nd Apr 202412:38 pmRNSTotal Voting Rights
21st Mar 20242:17 pmRNSAnnual Financial Report
19th Mar 20243:45 pmRNSAdditional Listing
5th Mar 20243:05 pmRNSDirector/PDMR Shareholding
5th Mar 20243:04 pmRNSDirector/PDMR Shareholding
5th Mar 20242:53 pmRNSDirector/PDMR Shareholding
4th Mar 20243:49 pmRNSDirector/PDMR Shareholding
4th Mar 20243:49 pmRNSDirector/PDMR Shareholding
1st Mar 20243:19 pmRNSTotal Voting Rights
22nd Feb 20247:00 amRNSRESULTS FOR THE FULL YEAR ENDED 31 DECEMBER 2023
5th Feb 20247:00 amRNSNotice of Full Year Results
1st Feb 202410:25 amRNSTotal Voting Rights
19th Jan 20244:14 pmRNSHolding(s) in Company
17th Jan 20245:11 pmRNSHolding(s) in Company
12th Jan 20243:25 pmRNSHolding(s) in Company
2nd Jan 202412:21 pmRNSTotal Voting Rights
12th Dec 20237:00 amRNSDirectorship Changes
7th Dec 20235:40 pmRNSHolding(s) in Company
6th Dec 20234:33 pmRNSHolding(s) in Company
1st Dec 202312:13 pmRNSTotal Voting Rights
23rd Nov 20237:00 amRNSDirectorship Changes
22nd Nov 20232:31 pmRNSAdditional Listing
3rd Nov 20234:15 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSTrading Update
1st Nov 202311:14 amRNSTotal Voting Rights
26th Oct 20234:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.